Trends in Spending and Claims for P2Y12 Inhibitors by Medicare and Medicaid From 2015 to 2020

被引：1
|
作者：
Essa, Mohammed [2 ]
Ross, Joseph S. S. [3 ,4 ,5 ]
Dhruva, Sanket S. S. [6 ]
Desai, Nihar R. R. [7 ]
Yeh, Robert W. W. [8 ]
Faridi, Kamil F. F. [1 ,7 ]
机构：
[1] Yale Sch Med, Dept Med, Sect Cardiovasc Med, Courier 333 Cedar St,Off 310 Dana, New Haven, CT 06520 USA
[2] Catholic Med Ctr, New England Heart & Vasc Inst, Manchester, NH USA
[3] Yale New Haven Hlth Syst, Ctr Outcomes Res & Evaluat, New Haven, CT USA
[4] Yale Sch Med, Dept Med, Sect Gen Internal Med, New Haven, CT 06520 USA
[5] Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA
[6] Univ Calif San Francisco, Sch Med, Dept Med, Sect Cardiol, San Francisco, CA USA
[7] Yale New Haven Hlth Syst, Ctr Outcomes Res & Evaluat, Yale Sch Med, Sect Cardiovasc Med,Dept Med, New Haven, CT USA
[8] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USA
来源：
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2023年 / 12卷 / 08期
关键词：
clopidogrel; medication costs; prasugrel; ticagrelor;
D O I：
10.1161/JAHA.122.028869
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Trends in Spending for P2Y12 Inhibitors by Medicare and Medicaid
    Essa, Mohammed
    Ross, Joseph S.
    Dhruva, Sanket
    Desai, Nihar R.
    Yeh, Robert W.
    Faridi, Kamil
    CIRCULATION, 2022, 146
  • [2] Characteristics of new P2Y12 inhibitors: selection of P2Y12 inhibitors in clinical practice
    Golino, Paolo
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2013, 14 : S22 - S30
  • [3] New P2Y12 inhibitors
    Storey, Robert F.
    HEART, 2011, 97 (15) : 1262 - 1267
  • [4] New P2Y12 Inhibitors
    Cattaneo, Marco
    CIRCULATION, 2010, 121 (01) : 171 - 179
  • [5] P2Y12 inhibitors for the neurointerventionalist
    Borchert, Robin J.
    Simonato, Davide
    Hickman, Charlotte
    Fuschi, Maurizio
    Thibault, Lucie
    Henkes, Hans
    Fiorella, David
    Tan, Benjamin Y. Q.
    Yeo, Leonard L. L.
    Makalanda, Hegoda L.
    Wong, Ken
    Bhogal, Pervinder
    INTERVENTIONAL NEURORADIOLOGY, 2022, 28 (01) : 92 - 103
  • [6] Use of P2Y12 inhibitors among Medicaid beneficiaries between 2008 and 2018
    Fatani, Nayyra
    Fanikos, Christopher
    Ting, Clara
    Buckley, Leo F.
    Fanikos, John
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2019, 48 (04) : 539 - 541
  • [7] Use of P2Y12 inhibitors among Medicaid beneficiaries between 2008 and 2018
    Nayyra Fatani
    Christopher Fanikos
    Clara Ting
    Leo F. Buckley
    John Fanikos
    Journal of Thrombosis and Thrombolysis, 2019, 48 : 539 - 541
  • [8] Pharmacogenetics of P2Y12 receptor inhibitors
    Thomas, Cameron D. D.
    Williams, Alexis K. K.
    Lee, Craig R. R.
    Cavallari, Larisa H. H.
    PHARMACOTHERAPY, 2023, 43 (02): : 158 - 175
  • [9] Responsiveness to P2Y12 receptor inhibitors
    Esposito, Giovanni
    CURRENT OPINION IN CARDIOLOGY, 2011, 26 : S31 - S37
  • [10] P2Y12 Inhibitors Refill Gap Predicts Death in Medicare Beneficiaries on Chronic Dialysis
    Rasu, Rafia S.
    Phadnis, Milind A.
    Xavier, Christy
    Dai, Junqiang
    Hunt, Suzanne L.
    Jain, Nishank
    KIDNEY INTERNATIONAL REPORTS, 2024, 9 (07): : 2125 - 2133
12345